258 related articles for article (PubMed ID: 17728540)
1. Influence of subinhibitory concentrations of protein-synthesis-inhibiting antibiotics on production and release of the pneumococcal virulence factor pneumolysin in vitro.
Spreer A; von Ruden C; Mitchell TJ; Eiffert H; Nau R
Chemotherapy; 2007; 53(5):327-31. PubMed ID: 17728540
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro.
Anderson R; Steel HC; Cockeran R; von Gottberg A; de Gouveia L; Klugman KP; Mitchell TJ; Feldman C
J Antimicrob Chemother; 2007 Nov; 60(5):1155-8. PubMed ID: 17848373
[TBL] [Abstract][Full Text] [Related]
3. Clarithromycin Inhibits Pneumolysin Production via Downregulation of
Domon H; Isono T; Hiyoshi T; Tamura H; Sasagawa K; Maekawa T; Hirayama S; Yanagihara K; Terao Y
Microbiol Spectr; 2021 Oct; 9(2):e0031821. PubMed ID: 34468195
[TBL] [Abstract][Full Text] [Related]
4. Implication of pneumolysin as a virulence factor in Streptococcus pneumoniae endophthalmitis.
Ng EW; Samiy N; Rubins JB; Cousins FV; Ruoff KL; Baker AS; D'Amico DJ
Retina; 1997; 17(6):521-9. PubMed ID: 9428015
[TBL] [Abstract][Full Text] [Related]
5. Streptococcus pneumoniae deficient in pneumolysin or autolysin has reduced virulence in meningitis.
Hirst RA; Gosai B; Rutman A; Guerin CJ; Nicotera P; Andrew PW; O'Callaghan C
J Infect Dis; 2008 Mar; 197(5):744-51. PubMed ID: 18260758
[TBL] [Abstract][Full Text] [Related]
6. Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae.
Anderson R; Steel HC; Cockeran R; Smith AM; von Gottberg A; de Gouveia L; Brink A; Klugman KP; Mitchell TJ; Feldman C
J Antimicrob Chemother; 2007 Feb; 59(2):224-9. PubMed ID: 17218449
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of Macrolide-Induced Inhibition of Pneumolysin Release Involves Impairment of Autolysin Release in Macrolide-Resistant Streptococcus pneumoniae.
Domon H; Maekawa T; Yonezawa D; Nagai K; Oda M; Yanagihara K; Terao Y
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181369
[No Abstract] [Full Text] [Related]
8. Rapid microtubule bundling and stabilization by the Streptococcus pneumoniae neurotoxin pneumolysin in a cholesterol-dependent, non-lytic and Src-kinase dependent manner inhibits intracellular trafficking.
Iliev AI; Djannatian JR; Opazo F; Gerber J; Nau R; Mitchell TJ; Wouters FS
Mol Microbiol; 2009 Jan; 71(2):461-77. PubMed ID: 19040644
[TBL] [Abstract][Full Text] [Related]
9. Short-term rifampicin pretreatment reduces inflammation and neuronal cell death in a rabbit model of bacterial meningitis.
Spreer A; Lugert R; Stoltefaut V; Hoecht A; Eiffert H; Nau R
Crit Care Med; 2009 Jul; 37(7):2253-8. PubMed ID: 19487938
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 2 contributes to antibacterial defence against pneumolysin-deficient pneumococci.
Dessing MC; Florquin S; Paton JC; van der Poll T
Cell Microbiol; 2008 Jan; 10(1):237-46. PubMed ID: 17711480
[TBL] [Abstract][Full Text] [Related]
11. Reduced release of pneumolysin by Streptococcus pneumoniae in vitro and in vivo after treatment with nonbacteriolytic antibiotics in comparison to ceftriaxone.
Spreer A; Kerstan H; Böttcher T; Gerber J; Siemer A; Zysk G; Mitchell TJ; Eiffert H; Nau R
Antimicrob Agents Chemother; 2003 Aug; 47(8):2649-54. PubMed ID: 12878534
[TBL] [Abstract][Full Text] [Related]
12. Pneumolysin as a vaccine and drug target in the prevention and treatment of invasive pneumococcal disease.
Cockeran R; Anderson R; Feldman C
Arch Immunol Ther Exp (Warsz); 2005; 53(3):189-98. PubMed ID: 15995579
[TBL] [Abstract][Full Text] [Related]
13. Critical involvement of pneumolysin in production of interleukin-1alpha and caspase-1-dependent cytokines in infection with Streptococcus pneumoniae in vitro: a novel function of pneumolysin in caspase-1 activation.
Shoma S; Tsuchiya K; Kawamura I; Nomura T; Hara H; Uchiyama R; Daim S; Mitsuyama M
Infect Immun; 2008 Apr; 76(4):1547-57. PubMed ID: 18195026
[TBL] [Abstract][Full Text] [Related]
14. Acacetin inhibits Streptococcus pneumoniae virulence by targeting pneumolysin.
Li S; Lv Q; Sun X; Tang T; Deng X; Yin Y; Li L
J Pharm Pharmacol; 2020 Aug; 72(8):1092-1100. PubMed ID: 32390150
[TBL] [Abstract][Full Text] [Related]
15. Amino acid changes affecting the activity of pneumolysin alter the behaviour of pneumococci in pneumonia.
Alexander JE; Berry AM; Paton JC; Rubins JB; Andrew PW; Mitchell TJ
Microb Pathog; 1998 Mar; 24(3):167-74. PubMed ID: 9514638
[TBL] [Abstract][Full Text] [Related]
16. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia.
Rubins JB; Charboneau D; Paton JC; Mitchell TJ; Andrew PW; Janoff EN
J Clin Invest; 1995 Jan; 95(1):142-50. PubMed ID: 7814608
[TBL] [Abstract][Full Text] [Related]
17. Human lung mast cells mediate pneumococcal cell death in response to activation by pneumolysin.
Cruse G; Fernandes VE; de Salort J; Pankhania D; Marinas MS; Brewin H; Andrew PW; Bradding P; Kadioglu A
J Immunol; 2010 Jun; 184(12):7108-15. PubMed ID: 20483738
[TBL] [Abstract][Full Text] [Related]
18.
Gonzales J; Chakraborty T; Romero M; Mraheil MA; Kutlar A; Pace B; Lucas R
Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33671422
[TBL] [Abstract][Full Text] [Related]
19. The autolytic enzyme LytA of Streptococcus pneumoniae is not responsible for releasing pneumolysin.
Balachandran P; Hollingshead SK; Paton JC; Briles DE
J Bacteriol; 2001 May; 183(10):3108-16. PubMed ID: 11325939
[TBL] [Abstract][Full Text] [Related]
20. Viability and virulence of pneumolysin, pneumococcal surface protein A, and pneumolysin/pneumococcal surface protein A mutants in the ear.
Schachern PA; Tsuprun V; Goetz S; Cureoglu S; Juhn SK; Briles DE; Paparella MM; Ferrieri P
JAMA Otolaryngol Head Neck Surg; 2013 Sep; 139(9):937-43. PubMed ID: 24051749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
